For the quarter ended September 2025, Moderna (MRNA) reported revenue of $1.02 billion, down 45.4% over the same period last year. EPS came in at -$0.51, compared to $0.03 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $860.07 million, representing a surprise of +18.13%. The company delivered an EPS surprise of +76.28%, with the consensus EPS estimate being -$2.15.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and ...